- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0046789

Spanred Formulation Private Limited
About Spanred Formulation Private Limited
Data last updated:
Spanred Formulation Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC093266. Its GSTIN is 24AAXCS5006Q1ZM (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanal Rakeshbhai Shah and Rakeshkumar Jayantilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Plot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760.
As per the financials filed for FY 2019, the company reported a revenue of ₹45.67 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹46,466 (net margin 1%) and EBITDA of ₹1.03 Lakh (EBITDA margin 2.3%).
As per MCA filings, the company has open charges of ₹7.5 Lakh on record.
Spanred Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0046789). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Spanred Formulation
Contact details
Spanred Formulation Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spanred Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spanred Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spanred Formulation Private Limited, buy the company report.
Financials of Spanred Formulation Private Limited
FY 2019 filings availableSpanred Formulation Private Limited reported revenue of ₹45.67 Lakh (down 29% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year. EBITDA fell 34% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹45.67 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.03 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹46,466 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.3% | ||
| Net Profit Margin | 1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Spanred Formulation Private Limited, buy the company report.
Board of directors of Spanred Formulation Private Limited
Spanred Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanal Rakeshbhai Shah | Director | 07 Mar 2018 | 8 Years 7 Months | Current |
| Rakeshkumar Jayantilal Shah | Director | 08 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Spanred Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Proothvi Biotech Private Limited | ₹45.77 Lakh (FY 2025) | 118.0% | Nagpur, Maharashtra, India | |||
| Ctga Biopharma India Private Limited | ₹45.77 Lakh (FY 2025) | -11.0% | Hyderabad, Telangana, India | |||
| Curizo Meditech Private Limited | ₹45.73 Lakh (FY 2023) | 64.0% | Surat, Gujarat, India | |||
| Folis Allied Core Private Limited | ₹45.7 Lakh (FY 2020) | -31.0% | Secendrabad, Telangana, India | |||
| Espiritos India Private Limited | ₹45.69 Lakh (FY 2024) | -19.0% | Navi Mumbai, Maharashtra, India | |||
| Spanred Formulation Private Limitedthis company | ₹45.67 Lakh (FY 2019) | ₹46,466 | 1% | -29.0% | Vadodara, Gujarat, India | |
| Rajmeen Aromas Private Limited | ₹45.55 Lakh (FY 2025) | 133.0% | Vadodara, Gujarat, India | |||
| Lograns Pharma Private Limited | ₹45.53 Lakh (FY 2025) | 14.0% | Hyderabad, Telangana, India | |||
| Flycatcher Pharmaceuticals Private Limited | ₹45.52 Lakh (FY 2019) | 154.0% | Kattupakkam, Tamil Nadu, India | |||
| Stealth Oxygen Company Private Limited | ₹45.5 Lakh (FY 2022) | Jammu and Kashmir, India | ||||
| Kairali Paints Private Limited | ₹45.48 Lakh (FY 2015) | -7.0% | Ernakulam, Kerala, India |
To see the full peer comparison of Spanred Formulation Private Limited, buy the company report.
Auditor
Spanred Formulation Private Limited is audited by MINESH M SHAH & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MINESH M SHAH & CO | FY 2019 | 116492W |
Shareholding
The shareholding of Spanred Formulation Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Spanred Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jul 2018 | 100194068 | State Bank of India | ₹7.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Spanred Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spanred Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spanred Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAXCS5006Q1ZM | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spanred Formulation Private Limited, buy the company report.
Recent activity
Spanred Formulation Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Ashish Hasmukhbhai Patel ceased to be Director on 10 Mar 2018.
Frequently asked questions
Spanred Formulation is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC093266.
Spanred Formulation has 2 current directors:
- Kanal Rakeshbhai Shah - Director
- Rakeshkumar Jayantilal Shah - Director
The latest financial statements of Spanred Formulation on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Spanred Formulation is 24AAXCS5006Q1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Spanred Formulation is U74999GJ2016PTC093266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spanred Formulation was incorporated on 08 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Spanred Formulation by revenue are Proothvi Biotech Private Limited, Ctga Biopharma India Private Limited, Curizo Meditech Private Limited, Folis Allied Core Private Limited, Espiritos India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashish Hasmukhbhai Patel ceased to be Director on 10 Mar 2018. Ashishkumar Bhalchandra Dave ceased to be Director on 10 Mar 2018. Kanal Rakeshbhai Shah was appointed as Director on 07 Mar 2018. Spanred Formulation has 4 board changes on record in total.
Yes, Spanred Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0046789).
The registered office of Spanred Formulation is at Plot No 836 GIDC Waghodia, Vadodara, Gujarat, India – 391760.
Spanred Formulation operates in the pharma industry, in the drug formulation and development segment.